Description
Description
Retatrutide is a next-generation triple agonist peptide targeting the GIP, GLP-1, and glucagon receptors. It is one of the most advanced compounds under research for extreme fat loss, insulin sensitivity, and appetite suppression. It combines the benefits of GLP-1 receptor agonists with enhanced lipolytic and metabolic support.
In clinical research, Retatrutide has shown **superior weight reduction effects** compared to Semaglutide and Tirzepatide. It’s currently at the frontier of obesity, type 2 diabetes, and metabolic syndrome research. Due to its glucagon receptor activity, it may also promote lean mass preservation and energy expenditure.
Key Characteristics
| Feature | Description |
|---|---|
| Compound | Retatrutide |
| Form | Lyophilized Peptide (5mg or 10mg) |
| Primary Use | Fat loss, glucose regulation, energy metabolism research |
| Mechanism | Triple GIP/GLP-1/Glucagon receptor agonist |
| Benefit | Rapid fat loss, appetite control, lean mass support |
Benefits
- Accelerated weight loss vs other incretin mimetics
- Suppresses hunger and enhances satiety
- Improves blood sugar and insulin sensitivity
- Activates glucagon receptors for fat breakdown
- Potentially preserves lean mass during calorie deficits
Reviews
There are no reviews yet.